A Phase I/II Study of Carfilzomib in Combination With R-CHOP (CR-CHOP) for Patients With Diffuse Large B-cell Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 29 Sep 2016 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 29 Sep 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Oct 2017.
- 21 Jan 2016 Planned End Date changed from 1 May 2016 to 1 Oct 2016 as per ClinicalTrials.gov record.